Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dice Therapeutics, Inc. (DICE) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dice Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1645569.
Total stock buying since 2021: $116,013,062.
Total stock sales since 2021: $122,139,175.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,007,701 | $28,256,062 | 2,666,925 | $122,139,175 | 0 | $0 |
| 2022 | 1,640,000 | $59,860,000 | 0 | $0 | 0 | $0 |
| 2021 | 1,641,000 | $27,897,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 0 | $0 | 2,511,621 | $116,495,532 | 0 | $0 |
| 2023-05 | 0 | $0 | 126,545 | $4,788,966 | 0 | $0 |
| 2023-04 | 0 | $0 | 16,392 | $493,120 | 0 | $0 |
| 2023-03 | 1,007,701 | $28,256,062 | 12,367 | $361,557 | 0 | $0 |
| 2022-10 | 1,640,000 | $59,860,000 | 0 | $0 | 0 | $0 |
| 2021-09 | 1,641,000 | $27,897,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-22 | Rubin Michael P. (10% Owner) | Sale | 2,492,871 | 46.50 | 115,918,501 |
| 2023-06-01 | Jacobsen John R. (CSO) | Sale | 18,750 | 30.77 | 577,031 |
| 2023-05-05 | Scheller Richard H (Director) | Sale | 84,097 | 38.51 | 3,238,239 |
| 2023-05-03 | Robertson Scott M. (CFO & CBO) | Sale | 18,750 | 36.55 | 685,350 |
| 2023-05-03 | Timothy Lu (CMO) | Sale | 10,000 | 36.54 | 365,400 |
| 2023-05-03 | Judice Kevin (CEO) | Sale | 13,698 | 36.50 | 499,977 |
| 2023-04-18 | Jacobsen John R. (CSO) | Sale | 16,392 | 30.08 | 493,120 |
| 2023-03-31 | Jacobsen John R. (CSO) | Sale | 773 | 30.00 | 23,190 |
| 2023-03-30 | Shah Rajeev M. | Buy | 195,997 | 28.74 | 5,632,953 |
| 2023-03-29 | Jacobsen John R. (CSO) | Sale | 1,094 | 30.00 | 32,823 |
| 2023-03-29 | Shah Rajeev M. | Buy | 66,369 | 29.38 | 1,949,921 |
| 2023-03-28 | Jacobsen John R. (CSO) | Sale | 500 | 30.09 | 15,044 |
| 2023-03-28 | Shah Rajeev M. | Buy | 246,779 | 29.24 | 7,215,817 |
| 2023-03-27 | Shah Rajeev M. | Buy | 151,132 | 27.48 | 4,153,107 |
| 2023-03-24 | Shah Rajeev M. | Buy | 192,335 | 26.87 | 5,168,041 |
| 2023-03-23 | Shah Rajeev M. | Buy | 155,089 | 26.67 | 4,136,223 |
| 2023-03-17 | Scopa James Paul (Director) | Sale | 10,000 | 29.05 | 290,500 |
| 2022-10-17 | Shah Rajeev M. | Buy | 1,640,000 | 36.50 | 59,860,000 |
| 2021-09-17 | Rubin Michael P. (10% Owner) | Buy | 235,000 | 17.00 | 3,995,000 |
| 2021-09-17 | Shah Rajeev M. | Buy | 1,400,000 | 17.00 | 23,800,000 |
| 2021-09-15 | Scopa James Paul (Director) | Buy | 6,000 | 17.00 | 102,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of DICE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dice Therapeutics, Inc. (symbol DICE, CIK number 1645569) see the Securities and Exchange Commission (SEC) website.